Eventide Asset Management’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Eventide Asset Management’s Portfolio ETTX Stock Details ETTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-590,602	Closed	-$1.1M	–	149
2022 Q1	$1.1M	Hold	590,602	–	–	0.02%	136
2021 Q4	$1.29M	Hold	590,602	–	–	0.02%	143
2021 Q3	$1.97M	Hold	590,602	–	–	0.03%	151
2021 Q2	$1.58M	Hold	590,602	–	–	0.02%	148
2021 Q1	$1.26M	Sell	590,602 -288,939	-33%	-$821K	0.02%	152
2020 Q4	$2.06M	Hold	879,541	–	–	0.03%	144
2020 Q3	$1.71M	Hold	879,541	–	–	0.03%	133
2020 Q2	$2.47M	Hold	879,541	–	–	0.05%	123
2020 Q1	$2.13M	Hold	879,541	–	–	0.07%	108
2019 Q4	$4.3M	Buy	879,541 +487,028	+124%	+$2.64M	0.12%	84
2019 Q3	$2.29M	Sell	392,513 -487,028	-55%	-$3.27M	0.08%	93
2019 Q2	$5.52M	Hold	879,541	–	–	0.17%	85
2019 Q1	$5.78M	Hold	879,541	–	–	0.2%	89
2018 Q4	$3.48M	Buy	879,541 +106,985	+14%	+$705K	0.15%	95
2018 Q3	$8.14M	Buy	+772,556	New	+$8.12M	0.3%	84

Other funds holding ETTX

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Eventide Asset Management's ETTX Position: Q2 2022 in Review

Eventide Asset Management sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q2 2022, closing a stake of 590,602 shares — an estimated $1.1M sold.

Eventide Asset Management first reported a position in ETTX in Q3 2018 and held it in 15 quarters. The position peaked at $8.14M in Q3 2018. 27 funds tracked by Wall St. Rank hold ETTX as of Q2 2022.

Eventide Asset Management reported no remaining Entasis Therapeutics Holdings Inc. position as of Q2 2022 after selling out during the quarter.
Eventide Asset Management sold 590,602 Entasis Therapeutics Holdings Inc. shares in Q2 2022, an estimated $1.1M.
Eventide Asset Management first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2018 and held it in 15 quarters.
Eventide Asset Management's Entasis Therapeutics Holdings Inc. position peaked at $8.14M in Q3 2018.
27 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q2 2022.

Based on Eventide Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.